Vivian Wu | executive |
Howard W. Robin | executive |
Jonathan Zalevsky | executive |
Sandra Gardiner | executive |
Cheng Li | analyst |
Mary Tagliaferri | executive |
Kambiz Yazdi | analyst |
Jessica Fye | analyst |
Julian Harrison | analyst |
Good day, and thank you for standing by. Welcome to the Nektar Therapeutics Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions]. Please be advised today's conference is being recorded. I would now like to hand the conference over to your speaker today, Vivian Wu. Please go ahead.